Joel S. Marcus, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 10,000 shares at $52.49 ($523K) on 2022-11-07, disclosed to the SEC on 2022-11-08.
Open-market sale of $523k ITCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.11 | 5,000 | $261K | 49.8% |
| 2 | $52.49 | 5,000 | $262K | 50.2% |
| Total | $52.30 avg | 10,000 | $523K | 100% |
| Filing → |
| ARE | BUY | 2026-05-07 | $348K | — | Filing → |
| ARE | BUY | 2026-05-06 | $320K | — | Filing → |
| ARE | BUY | 2026-05-05 | $410K | — | Filing → |